期刊文献+

晚期非小细胞肺癌中LRP表达及其与NP方案化疗敏感性关系研究 被引量:1

下载PDF
导出
摘要 目的:探讨晚期非小细胞肺癌组织中肺耐药蛋白(lung resistance protein,LRP)表达水平与NP方案化疗耐药及预后的相关性。方法:应用免疫组化SP法检测72例非小细胞肺癌组织中LRP的表达并分析其与顺铂化疗耐药及1a生存率的关系。结果:晚期非小细胞肺癌癌组织LRP表达水平与非小细胞肺癌患者性别及组织学类型无关,而与非小细胞肺癌患者以NP化疗的耐药性有关。LRP的表达阳性患者1a生存率为25.7%,低于阴性患者的51.4%,有统计学意义(P<0.05)。结论:LRP在非小细胞肺癌组织中的表达水平与NP方案化疗耐药有关,LRP的高表达往往提示预后不佳。
出处 《临床医药实践》 2009年第9X期645-646,共2页 Proceeding of Clinical Medicine
  • 相关文献

参考文献1

二级参考文献19

  • 1徐敏,王树滨,刘雅洁,白桦,郑瑾,陈亦欣.P糖蛋白在乳腺癌原发灶和淋巴结转移灶中的表达及其临床意义[J].实用癌症杂志,2007,22(1):19-22. 被引量:3
  • 2王高雄,李新丰,孙旭日,邱建龙,陈凌岩,叶超平.耐药相关蛋白P—gP、GST-π、TopoⅡ在原发性肝癌中的表达及其临床意义[J].中华消化外科杂志,2007,6(1):44-47. 被引量:5
  • 3杨盛力,张万广,陈孝平,彭静,刘利平,靖凯.P糖蛋白与乙型肝炎病毒X蛋白在肝癌原发灶和门静脉癌栓中的表达及其临床意义[J].肝胆外科杂志,2007,15(4):302-305. 被引量:1
  • 4Tsuda H,Sata M,Ijuuin H,et al. A novel strategy for remission induction and maintenance in cancer therapy [J]. Oncol Rep,2002,9 ( 1 ) : 65-68.
  • 5Eid H, Geczi L, Magori A, et al . Drug resistance and sensitivity of germ cell testicular tumors : evaluation of clinical relevance of MDR1 / P2gp , P53, and metallothionein (MT) proteins[J]. Anticancer Res, 1998,18 (4c): 3059-3064.
  • 6Yeh JJ, Shu NY, Shu WH , et al. Comparison of chemotherapy response with P-glycoprotein, mullidrug resistance-related protein-1, and lung resistance-related protein expression in untreated small cell lung cancer[J] lung,2005,183 (3):177-183.
  • 7Wright S R, Boag A H, Valdimarsson, et al. Immunohistoehemieal deetection of multidrug resistance protein in human lung cancer and normal lung[J]. Clin Cancer Res, 1998,4(9) :2279-2289.
  • 8Kim R,Chi YJnoue H, et al.Expression and relationship between topoi-somerase I and Ⅱ alpha genes in tumor and normal tissues in esophageal, gastric and colon cancels [J]. Anticancer Res,1999,19 (6B) :5393-5398.
  • 9Suganuma K,KubotaT, Saikawa Y , et al. Possible chemoresistance-related genes for gastric cancer detected by cDNA microarray[J]. Cancer Sci, 2003,94(4) :355-359.
  • 10Tsukamoto F, Shiba E, Taguchi T, et al. Immunohistochemical detection of P-glycoprotein in breast cancer and its significance as a prognostic factor[J]. Breast cancer, 1997, 4(4) : 259-263.

共引文献3

同被引文献18

  • 1陈元鸿,王婉梅,王皓,李红艳.埃索美拉唑三联与奥美拉唑三联疗法治疗Hp阳性十二指肠溃疡对比研究[J].第一军医大学学报,2005,25(8):1045-1047. 被引量:82
  • 2宋晓荣,姬明丽.LRP的表达与非小细胞肺癌耐药性的关系[J].齐齐哈尔医学院学报,2006,27(4):393-395. 被引量:4
  • 3黄锡梅,苏炳光,吴春林.TP与NP方案治疗晚期非小细胞肺癌对比观察[J].实用全科医学,2007,5(4):306-307. 被引量:4
  • 4Bouhamyia L,Chantot-Bastaraud S,Zaidi S,et al.Immunolo-ealization and cell expression of lung resistance related protein(LRP)in normal and tumoral human respiratory ceils[J].JHC, 2007,55(8):773.
  • 5Scherffer GL,W ijrgaard Pl, FlensMJ,et al.The drug resestance-related protein LRP is the human major vault protein[J].NatMed, 1995, 1 : 578.
  • 6Kawnbate S, Oka M, Shiozawa K,et al. Breast cancer resistance protein directly confers SN 38 resistance of lung cancer cells [J]. Biochem Biophys Res Common, 2001,280(5) : 1216.
  • 7Rybarova S, Hajdukova M, Hodorova I, et a.l Expression of themultidrug resistanee-assoeiated protein l(MRP1)and the lung resist-ance-related protein(LRP) in human lung cancer[J].Neoplasma,2004, 51(3):169.
  • 8Scheper GI, Schroeijers AB, Izquierdo MA,et al. Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer [J].Curr Opin Oncol,2000,12(6):550.
  • 9Herlevsen M ,Oxford G,Owens CR,et al.Depletion of major vault protein increases doxombicin sensitivity and nuclear at-cumulation and disrupts its sequestration in lysosomes[J].Mol Cancer Ther, 2007, 6(6) : 1804.
  • 10Meschini S, Macra M, Calcabrini A, et al.Role of the lung resistance-related protein (LRP) in the drug sensitivity of cultured tumor cells[J].Toxicol in Vitro,2002,16(4) : 389.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部